These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16320134)

  • 1. Ajulemic acid.
    Wiley JL
    IDrugs; 2005 Dec; 8(12):1002-11. PubMed ID: 16320134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials.
    Burstein S
    AAPS J; 2005 Jun; 7(1):E143-8. PubMed ID: 16146336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain reduction and lack of psychotropic effects with ajulemic acid: comment on the article by Sumariwalla et al.
    Burstein S; Zurier RB
    Arthritis Rheum; 2004 Dec; 50(12):4078-9; author reply 4079-80. PubMed ID: 15593192
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.
    Mitchell VA; Aslan S; Safaei R; Vaughan CW
    Neurosci Lett; 2005 Jul; 382(3):231-5. PubMed ID: 15925096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comments on "cannabimimetic properties of ajulemic acid".
    Karst M
    J Pharmacol Exp Ther; 2007 Jul; 322(1):420-1. PubMed ID: 17578903
    [No Abstract]   [Full Text] [Related]  

  • 6. Ajulemic acid: potential treatment for chronic inflammation.
    Burstein SH
    Pharmacol Res Perspect; 2018 Apr; 6(2):e00394. PubMed ID: 29638269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.
    Tepper MA; Zurier RB; Burstein SH
    Bioorg Med Chem; 2014 Jul; 22(13):3245-51. PubMed ID: 24856183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ajulemic acid: A novel cannabinoid produces analgesia without a "high".
    Burstein SH; Karst M; Schneider U; Zurier RB
    Life Sci; 2004 Aug; 75(12):1513-22. PubMed ID: 15240185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ajulemic acid (CT3): a potent analog of the acid metabolites of THC.
    Burstein SH
    Curr Pharm Des; 2000 Sep; 6(13):1339-45. PubMed ID: 10903396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of voltage-gated Na⁺ channels by the synthetic cannabinoid ajulemic acid.
    Foadi N; Berger C; Pilawski I; Stoetzer C; Karst M; Haeseler G; Wegner F; Leffler A; Ahrens J
    Anesth Analg; 2014 Jun; 118(6):1238-45. PubMed ID: 24755846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive allosteric modulatory effects of ajulemic acid at strychnine-sensitive glycine alpha1- and alpha1beta-receptors.
    Ahrens J; Leuwer M; Demir R; Krampfl K; de la Roche J; Foadi N; Karst M; Haeseler G
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Apr; 379(4):371-8. PubMed ID: 18985319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids, inflammation, and fibrosis.
    Zurier RB; Burstein SH
    FASEB J; 2016 Nov; 30(11):3682-3689. PubMed ID: 27435265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allylbenzene analogs of delta9-tetrahydrocannabinol as tumor growth inhibitors.
    Nichols DE; Mason DL; Jacobsen LB
    Life Sci; 1977 Nov; 21(9):1245-8. PubMed ID: 927027
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabimimetic properties of ajulemic acid.
    Vann RE; Cook CD; Martin BR; Wiley JL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):678-86. PubMed ID: 17105826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols.
    Papahatjis DP; Nikas SP; Andreou T; Makriyannis A
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3583-6. PubMed ID: 12443781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs derived from cannabinoids. 7. Tachycardia and analgesia structure-activity relationships in delta9-tetrahydrocannabinol and some synthetic analogues.
    Osgood PF; Howes JF; Razdan RK; Pars HG
    J Med Chem; 1978 Aug; 21(8):809-11. PubMed ID: 691006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hashish. Unsaturated side-chain analogues of delta8-tetrahydrocannabinol with potent biological activity.
    Razdan RK; Dalzell HC; Herlihy P; Howes JF
    J Med Chem; 1976 Nov; 19(11):1328-30. PubMed ID: 1003411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid.
    Liu J; Li H; Burstein SH; Zurier RB; Chen JD
    Mol Pharmacol; 2003 May; 63(5):983-92. PubMed ID: 12695526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol.
    Hollister LE
    Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.